Cargando…

Effect of Preexisting Immunity to Tetanus Toxoid on the Efficacy of Tetanus Toxoid-Conjugated Heroin Vaccine in Mice

Opioid use disorder (OUD) is a serious health problem that has dramatically increased over the last decade. Although current therapies for the management of OUD can be effective, they have limitations. The complementary strategy to combat the opioid crisis is the development of a conjugate vaccine t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Komla, Essie, Torres, Oscar B., Jalah, Rashmi, Sulima, Agnieszka, Beck, Zoltan, Alving, Carl R., Jacobson, Arthur E., Rice, Kenner C., Matyas, Gary R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8229309/ https://www.ncbi.nlm.nih.gov/pubmed/34205869 http://dx.doi.org/10.3390/vaccines9060573

Ejemplares similares

Immunization with Tetanus Toxoid: The Recall Response
por: Strenge, Henry B.
Publicado: (1940)

Tetanus toxoid immunization to reduce mortality from neonatal tetanus
por: Blencowe, Hannah, et al.
Publicado: (2010)

Serum Sickness following Tetanus Toxoid Injection
por: alhawal, Saja, et al.
Publicado: (2021)

Bivalent Conjugate Vaccine Induces Dual Immunogenic Response That Attenuates Heroin and Fentanyl Effects in Mice
por: Barrientos, Rodell C., et al.
Publicado: (2021)

Engineering of tetanus toxoid-loaded polymeric microneedle patches
por: Arshad, Muhammad Sohail, et al.
Publicado: (2022)

Comparative Immunogenicity of the Tetanus Toxoid and Recombinant Tetanus Vaccines in Mice, Rats, and Cynomolgus Monkeys
por: Yu, Rui, et al.
Publicado: (2016)

A Stable Heroin Analogue That Can Serve as a Vaccine Hapten to Induce Antibodies That Block the Effects of Heroin and Its Metabolites in Rodents and That Cross-React Immunologically with Related Drugs of Abuse
por: Sulima, Agnieszka, et al.
Publicado: (2017)

Cost of Delivering Tetanus Toxoid and Tetanus-Diphtheria Vaccination in Vietnam and the Budget Impact of Proposed Changes to the Schedule
por: Mai, Vu Quynh, et al.
Publicado: (2022)

Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines
por: Lockyer, Kay, et al.
Publicado: (2015)

Preclinical development of the quadrivalent meningococcal (ACYW) tetanus toxoid conjugate vaccine, MenQuadfi®
por: Kensinger, Richard, et al.
Publicado: (2022)

Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant
por: Torres, Oscar B., et al.
Publicado: (2017)

Degradomics-Based Analysis of Tetanus Toxoids as a Quality Control Assay
por: Michiels, Thomas J. M., et al.
Publicado: (2020)

Guillain-Barré syndrome after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine: a case report
por: Ammar, Hussam
Publicado: (2011)

Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization
Publicado: (1993)

Efficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine
por: Quiambao, Beatriz, et al.
Publicado: (2020)

Tetanus Toxoid‐Pulsed Monocyte Vaccination for Augmentation of Collateral Vessel Growth
por: Herold, Joerg, et al.
Publicado: (2014)

Maternal Tetanus Toxoid Vaccination and Neonatal Mortality in Rural North India
por: Singh, Abhishek, et al.
Publicado: (2012)

A rare case of cellulitis after tetanus toxoid (TT) vaccination
por: AlBassri, Tala K., et al.
Publicado: (2020)

Living standard and access to tetanus toxoid immunization among women in Bangladesh
por: Islam, Ummay Nayeema, et al.
Publicado: (2022)

In vivo Evaluation of Single Dose Tetanus Toxoid Vaccine Formulation with Chitosan Microspheres
por: Manivannan, R., et al.
Publicado: (2008)

Post-licensure safety surveillance study of routine use of tetanus toxoid, reduced diphtheria toxoid and 5-component acellular pertussis vaccine
por: Baxter, Roger, et al.
Publicado: (2016)

Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study
por: Zambrano, Betzana, et al.
Publicado: (2023)

Transcriptomic Response of Porcine PBMCs to Vaccination with Tetanus Toxoid as a Model Antigen
por: Adler, Marcel, et al.
Publicado: (2013)

Tetanus toxoid and CCL3 improve DC vaccines in mice and glioblastoma patients
por: Mitchell, Duane A., et al.
Publicado: (2015)

Maternal Tetanus Toxoid Vaccination in Benin: Evidence from the Demographic and Health Survey
por: Amoak, Daniel, et al.
Publicado: (2022)

Characterization and optimization of heroin hapten-BSA conjugates: method development for the synthesis of reproducible hapten-based vaccines
por: Torres, Oscar B., et al.
Publicado: (2014)

Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2019
por: Havers, Fiona P., et al.
Publicado: (2020)

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) vs. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study
por: van der Vliet, D., et al.
Publicado: (2021)

Impairment of humoral and cellular immune response to tetanus toxoid in HTLV-1 infected individuals
por: Souza, Anselmo S, et al.
Publicado: (2014)

Diversity of the Antibody Response to Tetanus Toxoid: Comparison of Hybridoma Library to Phage Display Library
por: Sorouri, Mahsa, et al.
Publicado: (2014)

Nanoporous Microneedle Arrays Effectively Induce Antibody Responses against Diphtheria and Tetanus Toxoid
por: de Groot, Anne Marit, et al.
Publicado: (2017)

Knowledge and health beliefs of reproductive-age women in Alexandria about tetanus toxoid immunization
por: Mehanna, Azza, et al.
Publicado: (2020)

CD154 Expression Indicates T Cell Activation Following Tetanus Toxoid Vaccination of Horses
por: Schnabel, Christiane L., et al.
Publicado: (2022)

Adjuvant Effect of Whole-Cell Pertussis Component on Tetanus Toxoid Potency in Murine Model
por: Prygiel, Marta, et al.
Publicado: (2023)

Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein – conjugated pneumococcal vaccine in Filipino infants
por: Capeding, Maria Z Rosario, et al.
Publicado: (2003)

A rapid solution-based method for determining the affinity of heroin hapten-induced antibodies to heroin, its metabolites, and other opioids
por: Torres, Oscar B., et al.
Publicado: (2018)

Definition of Human Epitopes Recognized in Tetanus Toxoid and Development of an Assay Strategy to Detect Ex Vivo Tetanus CD4(+) T Cell Responses
por: da Silva Antunes, Ricardo, et al.
Publicado: (2017)

Prevalence of protective tetanus antibodies and immunological response following tetanus toxoid vaccination among men seeking medical circumcision services in Uganda
por: Makumbi, Fredrick, et al.
Publicado: (2018)

Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10–25 Years of Age
por: Halperin, Scott A., et al.
Publicado: (2014)

An O-Specific Polysaccharide/Tetanus Toxoid Conjugate Vaccine Induces Protection in Guinea Pigs against Virulent Challenge with Coxiella burnetii
por: Graves, Stephen R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k7aalki2j9c7pa4bfdb7la292v